| Literature DB >> 25424159 |
Emre Yalcinkaya1, Uygar Cagdas Yuksel2, Murat Celik2, Hasan Kutsi Kabul2, Cem Barcin2, Yalcin Gokoglan2, Erkan Yildirim2, Atila Iyisoy2.
Abstract
BACKGROUND: Neutrophil-to-lymphocyte ratio (NLR) has been found to be a good predictor of future adverse cardiovascular outcomes in patients with ST-segment elevation myocardial infarction (STEMI). Changes in the QRS terminal portion have also been associated with adverse outcomes following STEMI.Entities:
Mesh:
Year: 2014 PMID: 25424159 PMCID: PMC4375654 DOI: 10.5935/abc.20140179
Source DB: PubMed Journal: Arq Bras Cardiol ISSN: 0066-782X Impact factor: 2.000
Basal demographic and clinical characteristics
| Grade 2 Ischemia (n = 126) | Grade 3 Ischemia (n = 77) | p | ||
|---|---|---|---|---|
| Age, (years) | 59.15 ± 13.36 | 60.83 ± 13.71 | 0.391 | |
| Male, n (%) | 103 (81.7) | 60 (77.9) | 0.312 | |
| Hypertension, n (%) | 56 (44.4) | 38 (49.4) | 0.296 | |
| Hyperlipidemia, n (%) | 39 (31.2) | 15 (19.5) | 0.047 | |
| Diabetes mellitus, n (%) | 30 (24) | 21 (27.3) | 0.360 | |
| Smoking, n (%) | 37 (29.4) | 22 (28.6) | 0.517 | |
| Previous coronary artery disease, n (%) | 32 (25.4) | 15 (19.5) | 0.213 | |
| Admission systolic blood pressure, (mmHg) | 129.79 ± 23.63 | 133.89 ± 22.83 | 0.231 | |
| Admission diastolic blood pressure, (mmHg) | 76.24 ± 13.80 | 78.86 ± 16.47 | 0.229 | |
| Admission heart rate, (bpm) | 76.69 ± 11.79 | 78.92 ± 11.51 | 0.188 | |
| Time from symptoms to admission (hour) | 4.36 ± 3.18 | 5.15 ± 3.88 | 0.129 | |
| Hospitalization (days) | 5.26 ± 1.23 | 5.44 ± 1.38 | 0.359 | |
| Left ventricular ejection fraction (%) | 48.44 ± 7.61 | 44.58 ± 7.23 | 0.001 | |
| Anterior myocardial infarction, n (%) | 50 (39.7) | 46 (61.0) | 0.002 | |
| Left anterior descending artery | 50 (39.7) | 46 (59.7) | 0.031 | |
| Circumflex artery | 26 (20.6) | 14 (18.2) | ||
| Right coronary artery | 46 (36.5) | 15 (19.5) | ||
| LMCA/SVG/intermediate/diagonal/ obtuse | 4 (3.2) | 2 (2.6) | ||
| PCI with stent implantation, n (%) | 87 (69.0) | 60 (77.9) | 0.112 | |
| Complete | 109 (86.5) | 54 (70.1) | 0.008 | |
| Partial | 14 (11.1) | 15 (19.5) | ||
| No | 3 (2.4) | 8 (10.4) | ||
LMCA: left main coronary artery, SVG: saphenous vein graft, PCI: percutaneous coronary intervention.
Hematological and biochemical parameters
| Grade 2 Ischemia (n = 126) | Grade 3 Ischemia (n = 77) | p | ||
|---|---|---|---|---|
| Serum glucose (mg/dL) | 141.36 ± 56.51 | 155.85 ± 60.00 | 0.085 | |
| Urea, (mg/dL) | 37.78 ± 15.92 | 41.88 ± 19.18 | 0.102 | |
| Creatinine, (mg/dL) | 1.08 ± 0.33 | 1.19 ± 0.81 | 0.194 | |
| Serum uric acid, (mg/dL) | 6.08 ± 1.64 | 5.98 ± 2.09 | 0.759 | |
| High-density lipoprotein cholesterol, (mg/dL) | 41.08 ± 8.41 | 39.68 ± 8.07 | 0.260 | |
| Low-density lipoprotein cholesterol, (mg/dL) | 118.44 ± 35.55 | 112.49 ± 40.70 | 0.296 | |
| Triglycerides, (mg/dL) | 140.48 ± 77.64 | 151.47 ± 141.43 | 0.494 | |
| Total serum cholesterol, (mg/dL) | 186.99 ± 39.37 | 177.10 ± 45.20 | 0.117 | |
| White blood cells, (103 µL) | 11. 40 ± 33.34 | 12.30 ± 40.52 | 0.088 | |
| Neutrophils, (103 µL) | 7.45 ± 3.15 | 8.95 ± 4.03 | 0.004 | |
| Lymphocytes, (103 µL) | 2.86 ± 1.55 | 2.28 ± 1.47 | 0.010 | |
| Neutrophil / lymphocyte ratio | 3.40 ± 2.38 | 5.51 ± 3.90 | < 0.001 | |
| Hemoglobin, (g/dL) | 14.12 ± 1.93 | 14.05 ± 2.16 | 0.800 | |
| Hematocrit, (%) | 41.51 ± 5.19 | 41.19 ± 5.61 | 0.682 | |
| Platelet count, (103 µL) | 252.11 ± 72.25 | 254.54 ± 73.70 | 0.818 | |
| Mean platelet volume, (fL) | 8.24 ± 1.01 | 8.27 ± 0.95 | 0.833 | |
| Red cell distribution width (%) | 12.78 ± 1.27 | 13.09 ± 1.82 | 0.170 | |
Univariate and multivariate regression models based on independent variables likely to predict the neutrophil-to-lymphocyte (NLR) ratio
| Independent variables | Univariate Analysis | Multivariate
Analysis | ||
|---|---|---|---|---|
| Beta | p | Beta | p | |
| STR | 0.432 | < 0.001 | 2.527 | < 0.001 |
| Electrocardiographic ischemia grade | 0.321 | < 0.001 | 1.497 | 0.001 |
| Time from symptoms to admission (min) | 0.162 | 0.028 | 0.052 | 0.383 |
| In-hospital mortality | 0.189 | 0.007 | -2.445 | 0.025 |
| Hospitalization duration (days) | 0.165 | 0.019 | 0.114 | 0.558 |
| Admission SBP | -0.151 | 0.033 | -0.016 | 0.081 |
| Serum glucose | 0.159 | 0.023 | 0.003 | 0.555 |
| Serum urea | 0.187 | 0.008 | 0.023 | 0.080 |
| Hyperlipidemia | -0.081 | 0.251 | -0.009 | 0.985 |
| LVEF | -0.123 | 0.087 | -0.029 | 0.319 |
| Anterior MI | 0.012 | 0.870 | 0.566 | 0.230 |
| Infarct-related artery | -0.018 | 0.803 | -0.377 | 0.428 |
= p value at the last step with the independent variables that remained in model.
NLR: neutrophil-to-lymphocyte ratio; STR: ST-segment resolution; SBP: systolic blood pressure; LVEF: left ventricular ejection fraction; MI: myocardial infarction.
Effects of different variables on ECG ischemia grade in multivariate logistic regression analyses
| Covariates | Adjusted OR | 95% CI | p |
|---|---|---|---|
| NLR | 1.254 | 1.120-1.403 | < 0.001 |
| Anterior MI | 2.016 | 0.979-4.151 | 0.050 |
| Admission SBP | 1.015 | 1.000-1.030 | 0.075 |
| Hyperlipidemia | 2.107 | 0.927-4.789 | 0.051 |
| LVEF | 0.952 | 0.906-1.000 | 0.185 |
OR: odds ratio; 95% CI: 95% confidence interval; NLR: neutrophil-to-lymphocyte ratio; MI: myocardial infarction; SBP: systolic blood pressure; LVEF: left ventricular ejection fraction.